715

(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-A MINE

Created:	2004-08-16
Last modified:	2020-06-05

Find Related PDB Entry
3 entries where 715 is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	43
Chiral Atom Count	1
Bond Count	45
Aromatic Bond Count	11

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-A MINE
Synonyms	Sitagliptin
Systematic Name (OpenEye OEToolkits)	(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
Formula	C₁₆ H₁₅ F₆ N₅ O
Molecular Weight	407.314
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	Fc1cc(c(F)cc1F)CC(N)CC(=O)N3Cc2nnc(n2CC3)C(F)(F)F
SMILES	CACTVS	3.341	N[CH](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc3cc(F)c(F)cc3F
SMILES	OpenEye OEToolkits	1.5.0	c1c(c(cc(c1F)F)F)CC(CC(=O)N2CCn3c(nnc3C(F)(F)F)C2)N
Canonical SMILES	CACTVS	3.341	N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc3cc(F)c(F)cc3F
Canonical SMILES	OpenEye OEToolkits	1.5.0	c1c(c(cc(c1F)F)F)C[C@H](CC(=O)N2CCn3c(nnc3C(F)(F)F)C2)N
InChI	InChI	1.03	InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m1/s1
InChIKey	InChI	1.03	MFFMDFFZMYYVKS-SECBINFHSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB01261
Name	Sitagliptin
Groups	approved investigational
Description	Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus[FDA label,A2260,A2255,A2256]. The effect of this medication leads to glucose dependent increases in insulin and decreases in glucagon to improve control of blood sugar[FDA label,A2255]. Sitagliptin was granted FDA approval on October 16, 2006[L6061].
Synonyms	Sitagliptin malate Sitagliptin phosphate Sitagliptin hydrochloride monohydrate Sitagliptinum Sitagliptin Sitagliptin fumarate Sitagliptin tartrate hemihydrate Sitagliptina Sitagliptine
Brand Names	Juvisync Prz-sitagliptin Ag-sitagliptin Nb-sitagliptin Pro-sitagliptin-metformin Sitagliptin Sun Jamp Sitagliptin Nra-sitagliptin Januvia Apo-sitagliptin Malate Janumet Brynovin Sandoz Sitagliptin-metformin XR Sitagliptin Accord Sitagliptin-metformin Ach-sitagliptin Sitagliptin - Metformin Nat-sitagliptin PMS-sitagliptin Tartrate/metformin Prz-sitagliptin-metformin Ristaben Sandoz Sitagliptin Apo-sitagliptin/metformin XR Sandoz Sitagliptin-metformin Auro-sitagliptin Velmetia Efficib Ag-sitagliptin Hydrochloride / Metformin Steglujan Apo-sitagliptin-metformin Sitagliptin and Metformin Hydrochloride Ristfor Sitagliptin Mint-sitagliptin Pro-sitagliptin Malate / Metformin Hydrochloride Janumet XR Riva-sitagliptin Tartrate/metformin Riva Sitagliptin/metformin Apo-sitagliptin Malate / Metformin Hydrochloride PMS-sitagliptin M-sitagliptin Reddy-sitagliptin and Metformin Hydrochloride Taro-sitagliptin Fumarate Teva-sitagliptin Malate / Metformin Auro-sitagliptin Hydrochloride and Metformin Hydrochloride Zituvimet Zituvimet XR Pro-sitagliptin Nb-sitagliptin-metformin Tesavel Sitagliptin/metformin Hydrochloride Sun Mint-sitagliptin/metformin Xelevia Teva-sitagliptin Malate Bio-sitagliptin Apo-sitagliptin Riva Sitagliptin Reddy-sitagliptin Pro-sitagliptin Malate Jamp Sitagliptin Hydrochloride / Metformin Sitagliptin Phosphate/Metformin Hydrochloride PMS-sitagliptin-metformin Sitagliptin and metformin hydrochloride Zituvio Sitagliptin/metformin Hydrochloride Accord
Indication	Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is not used to treat type 1 diabetes or patients with a history of pancreatitis.[L41220] It is also used in combination with [metformin] [L41215] or [ertugliflozin].[L41225]
Categories	Agents causing angioedema Alimentary Tract and Metabolism Blood Glucose Lowering Agents Cytochrome P-450 CYP2C8 Substrates Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Substrates DPP-IV Inhibitors Drugs that are Mainly Renally Excreted Drugs Used in Diabetes Enzyme Inhibitors Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Hypoglycemia-Associated Agents Incretins OAT3/SLC22A8 Substrates Oral Hypoglycemics P-glycoprotein substrates Protease Inhibitors Triazoles
ATC-Code	A10BH51 A10BD24 A10BD07 A10BD29 A10BH01 A10BD12
CAS number	486460-32-6

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Dipeptidyl peptidase 4	MKTPWKVLLGLLGAAALVTIITVPVVLLNKGTDDATADSRKTYTLTDYLK...	unknown	inhibitor
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate
Cytochrome P450 2C8	MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI...	unknown	substrate
ATP-dependent translocase ABCB1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	substrate
Organic anion transporter 3	MTFSEILDRVGSMGHFQFLHVAILGLPILNMANHNLLQIFTAATPVHHCR...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource Name	Reference
Pharos	CHEMBL1422
PubChem	4369359
ChEMBL	CHEMBL1422
ChEBI	CHEBI:40237

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.

Prepare Data

Validate Data

Deposit Data

Help and Resources

715

(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-A MINE

Find Related PDB Entry

Find related ligands:

Chemical Details

Chemical Component Summary

Chemical Descriptors

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Related Resource References